Please assess the completion status of the following clinical trial:

Trial Title: Comparison Of 5 CP-690,550 Doses Vs. Placebo, For The Treatment Of Rheumatoid Arthritis In Japan

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 6.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects must have failed an adequate trial of therapy with at least 1 DMARD due to lack of efficacy or toxicity.~Exclusion Criteria:~* Current therapy with any DMARD

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): None
- CP-690,550, 10mg (Type: EXPERIMENTAL): None
- CP-690,550, 15mg (Type: EXPERIMENTAL): None
- CP-690,550, 1mg (Type: EXPERIMENTAL): None
- CP-690,550, 3mg (Type: EXPERIMENTAL): None
- CP-690,550, 5mg (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).